Vigil Neuroscience’s $90 Million Series B Financing

Wilson Sonsini Goodrich & Rosati advised Vida Ventures on the deal while Goodwin Procter represented Vigil Neuroscience. Vigil Neuroscience, a biotechnology company harnessing the power of…

This content is for Standard 1 Year members only.
Login Join Now

Surgery Partners’ $800 Million High Yield Senior Notes Offering

SK Capital’s $2.95 Billion Closing of Fund VI

NRDC and BB Kapital’s Acquisition of Galeria

Mayakan Gas Pipeline’s Financing Round

MK Properties’ Acquisition of Cyrela Rosa Empreendimentos Imobiliarios

Atem’s Distribuidora de Petroleo’s R$100 Million Debentures Issuance

Apax Partners’ Acquisition of Zellis Group

Tychy’s Investment in Klub Pilkarski GKS Tychy

Trianon’s Shares Offering

KOKO Networks Limited’s Financing Round

India Vehicle Finance’s Notes Offering

Al-Arafa’s Demerger into Concrete Fashion Group and GTEX

SC Ventures’ $100 Million Joint Venture With SBI Holdings

GreenCorp’s Acquisition of Emad Bakeries

MedOne’s Agreement with Shikun and Binui Energy

SingleInterface’s $30 Million Series A Financing Round

Chery’s Joint Venture Agreement with Ebro-EV Motors

BT Global Business Services’ Merger with BT e-Serv

Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.

Hefesto Asesores continues to consolidate its position in the International Private Equity and Venture Capital market, with the formation of Hefesto Global

Paul Hastings Adds Premier Private Equity Buyout Team

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.

Paul Hastings Adds Premier Private Equity Buyout Team

BCLP Appoints Trevor Varnes as Chief Financial Officer

Vigil Neuroscience’s $90 Million Series B Financing

Author: Martina Bellini